» Articles » PMID: 30103327

Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2018 Aug 15
PMID 30103327
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The value of iron-based MRI changes for the diagnosis and staging of Alzheimer's disease (AD) depends on an association between cortical iron accumulation and AD pathology. Therefore, this study determined the cortical distribution pattern of MRI contrast changes in cortical regions selected based on the known distribution pattern of tau pathology and investigated whether MRI contrast changes reflect the underlying AD pathology in the different lobes. T2*-weighted MRI was performed on postmortem cortical tissue of controls, late-onset AD (LOAD), and early-onset AD (EOAD) followed by histology and correlation analyses. Combining ex vivo high-resolution MRI and histopathology revealed that: 1) LOAD and EOAD have a different distribution pattern of AD pathological hallmarks and MRI contrast changes over the cortex, with EOAD showing more severe MRI changes; 2) per lobe, severity of AD pathological hallmarks correlates with iron accumulation, and hence with MRI. Therefore, iron-sensitive MRI sequences allow detection of the cortical distribution pattern of AD pathology ex vivo.

Citing Articles

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review.

Mohammadi S, Ghaderi S, Fatehi F Aging Med (Milton). 2024; 7(5):649-667.

PMID: 39507230 PMC: 11535174. DOI: 10.1002/agm2.12363.


Microglia in Neurodegenerative Diseases.

Awogbindin I, Wanklin M, Verkhratsky A, Tremblay M Adv Neurobiol. 2024; 37:497-512.

PMID: 39207709 DOI: 10.1007/978-3-031-55529-9_27.


Distinct regional vulnerability to Aβ and iron accumulation in post mortem AD brains.

Yao J, Li Z, Zhou Z, Bao A, Wang Z, Wei H Alzheimers Dement. 2024; 20(10):6984-6997.

PMID: 39175425 PMC: 11485316. DOI: 10.1002/alz.14188.


Depth- and curvature-based quantitative susceptibility mapping analyses of cortical iron in Alzheimer's disease.

Merenstein J, Zhao J, Overson D, Truong T, Johnson K, Song A Cereb Cortex. 2024; 34(2).

PMID: 38185996 PMC: 10839848. DOI: 10.1093/cercor/bhad525.


References
1.
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K . Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006; 112(4):389-404. PMC: 3906709. DOI: 10.1007/s00401-006-0127-z. View

2.
Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H . Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008; 18(4):484-96. PMC: 2659377. DOI: 10.1111/j.1750-3639.2008.00147.x. View

3.
van Duijn S, Nabuurs R, van Rooden S, Maat-Schieman M, van Duinen S, van Buchem M . MRI artifacts in human brain tissue after prolonged formalin storage. Magn Reson Med. 2011; 65(6):1750-8. DOI: 10.1002/mrm.22758. View

4.
Frisoni G, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M . The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain. 2007; 130(Pt 3):720-30. DOI: 10.1093/brain/awl377. View

5.
Peters D, Connor J, Meadowcroft M . The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin. Neurobiol Dis. 2015; 81:49-65. PMC: 4672943. DOI: 10.1016/j.nbd.2015.08.007. View